Telomir Pharmaceuticals (TELO) Stock Chart & Stock Price History $1.13 -0.04 (-3.42%) Closing price 04:00 PM EasternExtended Trading$1.16 +0.03 (+2.21%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Telomir Pharmaceuticals Stock Price Performance The Telomir Pharmaceuticals (TELO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 72.71%, with a year-to-date return of -72.57%. In the past month, the stock has decreased 42.35%, reflecting recent market activity. As of the latest close, Telomir Pharmaceuticals traded at $1.17 with a market cap of $34.82 million and volume of 147,966 shares. Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.42%1 Month Performance-42.35%3 Month Performance-56.87%Year-To-Date Performance-72.57%1 Year Performance-72.71% TELO Stock Chart for Tuesday, July, 15, 2025 TELO Chart by TradingView Telomir Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$1.17$1.13-3.42%$1.20$1.13396,673 shs$33.63 million07/14/2025$1.16$1.17+0.86%$1.19$1.14147,966 shs$34.82 million07/11/2025$1.17$1.16-0.85%$1.18$1.12155,782 shs$34.52 million07/10/2025$1.18$1.17-0.43%$1.22$1.16123,254 shs$34.82 million07/09/2025$1.17$1.18+0.43%$1.20$1.17391,720 shs$34.97 million07/08/2025$1.15$1.17+1.74%$1.20$1.14179,794 shs$34.82 million07/07/2025$1.18$1.15-2.54%$1.17$1.13191,387 shs$34.22 million07/04/2025$1.18$1.18$1.20$1.15235,925 shs$35.12 million07/03/2025$1.18$1.18$1.20$1.15235,925 shs$35.12 million07/02/2025$1.27$1.18-7.09%$1.29$1.18267,671 shs$35.12 million Get the Latest News and Ratings for TELO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$1.25$1.27+1.60%$1.37$1.19868,378 shs$37.80 million06/30/2025$1.53$1.25-18.30%$1.58$1.25378,553 shs$37.20 million06/27/2025$1.70$1.53-10.00%$1.68$1.522.25 million shs$45.53 million06/26/2025$1.78$1.70-4.49%$1.79$1.61392,329 shs$50.59 million06/25/2025$1.76$1.78+1.14%$1.81$1.68311,626 shs$52.97 million06/24/2025$1.69$1.76+4.14%$1.76$1.65356,012 shs$52.38 million06/23/2025$1.76$1.69-3.98%$1.79$1.66297,807 shs$50.29 million06/20/2025$1.76$1.76$1.85$1.76486,066 shs$52.38 million06/19/2025$1.76$1.76$1.97$1.71187,458 shs$52.38 million06/18/2025$1.86$1.76-5.38%$1.97$1.71187,458 shs$52.38 million06/17/2025$2.00$1.86-7.00%$1.96$1.85148,490 shs$55.36 million06/16/2025$1.96$2.00+2.04%$2.00$1.92117,149 shs$59.53 million Related Companies Galectin Therapeutics Stock Price Chart Skye Bioscience Stock Price Chart Lyell Immunopharma Stock Price Chart Rapt Therapeutics Stock Price Chart Greenwich LifeSciences Stock Price Chart ALT5 Sigma Stock Price Chart Caribou Biosciences Stock Price Chart FitLife Brands Stock Price Chart Upexi Stock Price Chart Fate Therapeutics Stock Price Chart Receive TELO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TELO) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TELO Stock Alerts